Trial intelligence / Profile preview

ENDEAVOR: Neuridase for Peripheral Neuropathy in Urothelial Carcinoma

NCT07629700Not yet recruiting

Sponsor: Università degli Studi di Firenze
Start: Sep 2026
Primary completion: Sep 2027

Overview

Open-label, single-arm trial in urothelial carcinoma (UC) and peripheral neuropathy, sponsored by Università degli Studi di Firenze. Primary endpoint: Incidence and Severity of Peripheral Neuropathy at 6 months. Planned start Sep 2026; status: not yet recruiting.

Conditions

urothelial carcinoma (UC)peripheral neuropathy

Beyond the preview

Go deeper on NCT07629700.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07629700.